Author: eczemarelief
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several positive studies in hand, including a recent phase 3 trial pitting the candidate against the current standard-of-care, Leo says its delgocitinib has growth driver potential. Now, the drugmaker […]
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment of atopic dermatitis in adults and children aged ≥ 2 years, according to an announcement by the manufacturer, Dermavant Sciences. Tapinarof cream, 1% (VTAMA) is a steroid-free aryl hydrocarbon […]
TDM-180935 is a small-molecule drug candidate intended to treat atopic dermatitis. Credit: Kaspars Grinvalds / Shutterstock. Chinese biopharmaceutical company Technoderma Medicines has begun dosing patients in its Phase IIa clinical trial of topical TDM-180935 ointment, a potential treatment for atopic dermatitis (AD). The eight-week trial will assess the two different strengths of the topical medication […]
Stress causes a spike in the hormone cortisol, which may lead to eczema flare-ups. Avoiding stress and other triggers may help reduce flares. Atopic dermatitis, known as eczema, is a chronic inflammatory condition that may cause dry, itchy rashes to develop on your skin. These can sometimes be painful and could lead to feelings of […]